raises some interesting points on the interpretation of'... Nature cannot save us. It is thus for medicine and other disciplines to study this paranoid element and attempt to find ways to "cure" it'. In the sense of hermeneutics (conscious and unconscious interpretation) a terminological 'transplantation' is observed of experiences in the territory of function and structure. Consequently, if today we have a coincidence of the term with a psychological process, then it is not a question of an undifferentiated manifestation of fantasy-allegory or metaphore, but rather a question of syncretism, the reconciliation of philosophy and primitive culture. And as can be noticed, there is also proportion in the terminology used: everything is recognized to be 'in comparison with'.
With Hellenic spirit and Dyonysian profundity the terms come closer in subjective reflection from mythology into medicine. For example: the ancient Greek master renamed the thymos into a 'spiritual organ of aspirations', whereas Plato used this term for something when it is a question of anger or 'through anger'. Greek mythology has made it possible to unit thymos and fren as an 'intensive breathing' or as 'spasmodic breathing'. For Homer, the soul is entirely given to the thymos. But, as can be seen, the thymos is connected with reasonableness and patience, with a masculine principle ('the poor anatomical connection and the poor neurophysiological coordination').
In the character of medical language, sensory perceptive and palpable thinking has made itselffelt. Mythical intuition, as a superstructure offunction and human structure, has determined the closeness between medicine and mythology. Was it necessary for medicine to be torn between the Dracon and God! Even the latest science -genetic engineering -the name of the term 'Charon Factor', carries with it the fame of the boatman Charon of ancient Greek mythology. He ferried the souls of the dead across the river Styx with a minimum biological risk (}.. -fag branching factor causing mutation with a minimum biological risk). The name for psychopathology was also given by the millers of the island of Lesbos with their exorcism (expulsion by adjuration).
In this encounter of mythological terms in medicine we still seek a coincidence in life and images, the terminological roots. And we become convinced that there is a silent identification, deeply-sunk into itself; but it is not featureless although it has 'the collapse reticence'. This is our most important task. England and Wales as of September 1988, 300-500 were infected with the human immunodeficiency virus (HIV)2 and this number is likely to grow. This problem has been addressed: the European strategy for the care of HI V-infected prisoners, which stresses education, prevention, treatment and prophylaxis, has been outlined in two reports'':'. Since a proportion of these infected prisoners will ultimately develop AIDS during their prison sentences or may enter prison having already developed AIDS, the need for a strategy able to deliver high-quality medical and nursing care (and closely integrated with the community and hospital services) to these individuals will correspondingly be of paramount importance. A pivotal aspect of any effective care plan is the management and prevention of PCP, the commonest infection likely to develop in any patient with AIDS. Following acute therapy, secondary prophylaxis is crucial if a relapse is to be prevented. We describe what we believe to be the first documented report of delivering this form of prophylaxis to a prisoner with AIDS although it is probable that this may already be practised.
A 19-year-old HIV-seropositive injection drug user was initially treated in hospital for an acute episode of PCP. He received 12 days' treatment with a combination of co-trimoxazole and intravenous pentamidine isethionate and made a good recovery. At this juncture he took his own discharge from hospital. A few days later, he was arrested and sentenced to a term of imprisonment. During the subsequent 3 months in prison, he received zidovudine and AP prophylaxis (150 mg fortnightly). The latter was administered by the prison nurses after their being instructed on its use by the infectious diseases unit's community liaison nurse. During the period of incarceration the patient's compliance with treatment was good and he remained well.
This case demonstrates the successful use of aerosolized pentamidine prophylaxis in the prison setting, and underlines the versatility and adaptability of this technique. More importantly, provided there exists adequate support from community liaison nurses and specialist hospital infection services, AP can be successfully administered by appropriatelyeducated and motivated prison nurses and medical staff. It is clear from this that the adoption of preventative policies such as AP prophylaxis to prevent PCP could minimize the need to utilize outside hospital services or the proposed centralized prison hospital units, and indeed potentially cut the demand on these services by reducing the costs which might be incurred in treating large numbers of acutely ill patients.
